← Latest papers
🧬 biology

TACTIVS: Test-time actives induction for flexible target-specific virtual screening

TACTIVS is a test-time active induction framework that leverages a pretrained molecular foundation model to perform flexible, target-specific virtual screening by combining label-free calibration and connectivity-weighted graph propagation, achieving competitive enrichment without requiring model fine-tuning even when query and support actives belong to distinct chemical series.

Original authors: Douglas Houston, Lin Chen, Haoying Wang, Andreas Luttens, Pedro Ballester

Published 2026-10-09
📖 4 min read☕ Coffee break read

Original authors: Douglas Houston, Lin Chen, Haoying Wang, Andreas Luttens, Pedro Ballester

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

In the early stages of discovering a new medicine, scientists face a needle-in-a-haystack problem. They must sift through vast libraries containing millions of chemical compounds to find the handful that might successfully bind to a specific disease target and stop it from causing harm. Traditionally, researchers have relied on two main strategies to narrow this search. One approach looks at the physical shape of the target, like a lock, and tries to find a key that fits. The other looks at known working keys—molecules already proven to activate the target—and searches for others that look similar. While the first method requires detailed 3D maps of the target, the second relies on having at least one working example to start with. The challenge arises when scientists have very few examples, perhaps only a single confirmed active molecule, and need to find more without wasting time on millions of dead ends.

A team of researchers at the University of Edinburgh, Karolinska Institutet, and Imperial College London has developed a new method called TACTIVS to solve this specific problem. Instead of trying to retrain a complex computer model every time a new active molecule is discovered, which usually requires a large amount of data, TACTIVS works by instantly reorganizing how the computer views the entire library of chemicals. The system takes a frozen, pre-trained understanding of molecular shapes and uses the few known active molecules to immediately reshape the search. It does this by creating a map where the known active molecules act as beacons. The system then traces paths through the library, not just looking for molecules that look exactly like the beacons, but also for those that are connected to them through a chain of chemical similarities. This allows the system to find promising candidates that might look quite different from the starting examples but still belong to the same functional family.

The researchers tested this approach on several large, standard datasets used to benchmark virtual screening performance. In one test involving nearly 150 different biological targets, the new method was able to identify active molecules far more effectively than existing techniques when given just a single known active molecule. When the team increased the number of known active examples to ten, the method's ability to find the correct compounds improved significantly, outperforming both traditional shape-matching tools and other advanced learning-based systems. Crucially, the method proved it could find active molecules even when they were chemically distinct from the starting examples. In a strict test where the known active molecules and the target compounds came from completely different chemical families, the system still managed to rank the correct compounds much higher than random chance would allow. This suggests the method is not merely finding close copies of the starting molecules but is successfully navigating the broader chemical landscape to find new types of effective drugs.

The core of this success lies in how the system handles the data. Rather than adjusting the internal settings of the computer model to fit the new target, which can be unstable with very little data, the researchers adjusted the way the data is measured. They applied a mathematical transformation that removes background noise and highlights the specific differences that matter for the current search. This allows the system to see the relationships between molecules more clearly. By combining a direct comparison with the known active molecules and a broader analysis of how molecules are connected to one another in the library, the system creates a ranking that evolves as more information becomes available. If a scientist discovers a new active compound during an experiment, they can simply add it to the list, and the system instantly recalculates the rankings without needing to be retrained.

This work demonstrates that the value of a single experimental result can be maximized by using it to guide a flexible, library-wide search. The findings suggest that for many drug discovery campaigns, especially those where data is scarce, the most effective strategy is not to build a new model for every target, but to use a shared, robust understanding of chemistry and adapt the search strategy on the fly. The researchers found that as more active molecules were added to the reference set, the quality of the search improved steadily, confirming that the method learns from the accumulating evidence. By proving that a system can remain fixed while the search strategy adapts to new targets, this approach offers a practical and efficient path forward for identifying new medicines in the early, data-poor stages of discovery.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →